Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 May 2022 | Story Anthony Mthembu | Photo Edmund de Wet
House Ardour
Students of House Ardour along with other dignitaries cut the ribbon as they launch their new name.

The Health Sciences residence on the Bloemfontein Campus of the University of the Free State (UFS), commonly referred to as SHU 8, has been renamed House Ardour. The official launch of the residence name took place on Saturday, 7 May 2022 in the Callie Human Centre on the Bloemfontein Campus. “This is really a historic moment for us in Residence Affairs, Student Affairs, and I think for the university at large,” expressed the Assistant Director of Student Life at the UFS, Pulane Malefane. The launch takes place after two years of planning and discussions about an appropriate name for the residence. As such, the launch was well attended by some of the students living in the newly renamed residence, along with other dignitaries such as Prof Colin Chasi, Director of the Unit for Institutional Change and Social Justice, Quintin Koetaan, Senior Director of Housing and Residence Affairs, Prof Mpho Jama, Associate Professor in the Office of the Dean: Faculty of Health Sciences, and Nthabiseng Mokhethi who serves as Ardour’s Residence Head, among others.

Embracing a New Name

The name Ardour means to love, and to do something with great passion and enthusiasm. Malefane says the name is symbolic of the fact that many of the students in this residence will go out into the world and delineate those very values through their servitude. There has been a deep yearning from the student body for the renaming of the Health Sciences residence for quite some time. As such, the launch and celebration of this name is acknowledging the residence as part of the UFS community. “Names are important, names can carry deep personal, cultural, and historical connections, it also gives us a sense of who we are, the communities we belong to, and our places in the world,” Malefane highlighted during her speech in the Callie Human Centre.

The Importance of the Residence

Although this co-ed residence is not restricted to students within the Faculty of Health Sciences, the residence is a response to some of the problems that students in the faculty have been facing. “During recess when all the other students have to go home, some of our students still need to remain on campus or even come back earlier. This has created the need to say that we cannot allow our students to move between residences when they have such an academic workload that requires them to be in a space in which they don’t have to worry about where they are going to stay,” indicated Prof Jama. As such, the residence is also an essential way of ensuring that students from the Faculty of Health Sciences focus on developing academically as well as socially in the university space, without worrying about accommodation. 

Subsequent to a few remarks from the dignitaries at the Callie Human Centre, some of the guests descended to Ardour for the cutting of the ribbon. The ribbon was cut by Emily Chikobvu who serves as Ardour’s Prime, along with Quintin Koetaan, and Nthabiseng Mokhethi. “Moving forward, we do not want to hear the name Shoe 8 – that name is in the past – from now on we shall be referred to as House Ardour,” stated Vusimuzi Gqalane, Senior Assistant in the Unit for Institutional Change and Social Justice.


News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept